肥胖并非腹膜后入路开放腹主动脉瘤修复联合加速康复外科方案的 risk 因素
单中心回顾性队列研究纳入2016年1月至2022年12月连续接受择期腹膜后入路开放腹主动脉瘤修复联合加速康复外科方案的患者,比较53例肥胖(BMI≥30)与148例正常体重患者。两组术后总体并发症率无显著差异,肥胖组术后ICU入住率显著更低,住院时间、30天及1年死亡率、再干预率均无显著差异。
要点
- 肥胖组与正常体重组术后总体并发症率无显著差异(58.5% vs 56.8%,P=.889)。
- 肥胖组术后ICU入住率显著低于正常体重组(50.9% vs 30.4%,P<.05)。
- 两组住院时间、30天及1年死亡率、再干预率均无显著差异。
核心结论
- 肥胖本身不应负面影响治疗选择,前提是采用合适的手术策略。
研究设计与样本
- 单中心回顾性队列研究,纳入2016年1月至2022年12月所有连续接受择期腹膜后入路开放腹主动脉瘤修复联合加速康复外科方案的患者。
- 研究队列中识别出53例肥胖患者(体重指数≥30,组1)和148例正常体重患者(组2)。
- 主要终点为术后并发症、需重症监护入住和住院时间;次要终点为围手术期死亡率、1年总生存率和再干预率。
主要发现
- 两组术后总体并发症率无显著差异(组1 58.5% vs 组2 56.8%;P=.889)。
- 按Clavien-Dindo分类分层,轻微并发症率(组1 50.9% vs 组2 49.3%;P=.907)和严重并发症率(组1 7.5% vs 组2 7.4%;P=.979)均无显著差异。
- 肥胖组术后ICU入住率显著低于正常体重组(50.9% vs 30.4%;P<.05)。
- 两组住院时间无差异(5天[IQR 4.5-7.5天] vs 5天[IQR 4-7天];P=.794)。
- 30天死亡率(组1 98.6% vs 组2 100%;P=.395)和1年死亡率(组1 94.3% vs 组2 96.1%;P=.623)均无显著差异;研究期间两组均无再干预。
临床怎么用
- 原文结论认为肥胖本身不应负面影响治疗选择,前提是采用合适的手术策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity is a worldwide complex disease related to an increased risk of adverse outcomes in surgical patients, especially in abdominal aortic surgery. With the retroperitoneal approach, the abdominal fat falls to the right and the peritoneum opening is avoided, reducing invasiveness, and avoiding many technical challenges related to hostile abdomens. Furthermore, the combination of the Early Recovery After Surgery protocol is known to improve the outcome of abdominal surgery. especially in high-risk patients such as the obese population. METHODS: We conducted a single-center retrospective cohort study enrolling all consecutive patients undergoing elective open retroperitoneal aneurysm repair associated with the Early Recovery After Surgery protocol between January 2016 and December 2022. In the study cohort 53 obese (body mass index ≥30) (group 1) and 148 normal-weight patients (group 2) were identified. Primary end points were postoperative complications, need for intensive care admission, and length of hospital stay. Secondary end points were the perioperative mortality, overall survival and reinterventions rates at 1 year. RESULTS: No significant differences (group 1, 58.5% vs group 2, 56.8%; P = .889) were found between the two groups for the overall postoperative complications rates. The results were confirmed also stratifying the Clavien-Dindo classification for minor (group 1, 50.9% vs group 2, 49.3%; P = .907) or major (group 1, 7.5% vs group 2, 7.4%; P = .979) complications rates. Postoperative intensive care unit admissions were significantly lower for group 1 compared with group 2 (50.9% vs 30.4%; P < .05). Instead, the length of hospital stay did not show differences between the two groups (5 days [interquartile range (IQR), 4.5-7.5 days] vs 5 days [IQR, 4-7 days]; P = .794). The mean follow-up period was 11.5 months (IQR, 2-31 months) for group 1 and 13 months (IQR, 1-30 months) for group 2 (P = .966). No significant differences emerged regarding mortality both at 30 days (group 1, 98.6% vs group 2, 100%; P = .395) and at 1 year (group 1, 94.3% vs group 2, 96.1%; P = .623). Finally, no reinterventions, not even on the abdominal wall, were necessary in the two groups during the study period. CONCLUSIONS: Obesity, by itself, should not influence negatively the therapeutic choice if a proper surgical strategy is adopted.
引用
- Acciarri P, Ciofani L, Traina L, et al. Obesity is not a risk factor for open aortic aneurysm repair using retroperitoneal approach and ERAS protocol. J Vasc Surg. 2025. PMID: 40107520. doi:10.1016/j.jvs.2025.03.165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。